Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children
- PMID: 25473701
- Bookshelf ID: NBK258608
Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children
Excerpt
The global priorities for tuberculosis (TB) care and control are to improve case-detection and to detect cases earlier, including cases of smear-negative disease which are often associated with coinfection with the human immunodeficiency virus (HIV) and young age, and to enhance the capacity to diagnose multidrug-resistant tuberculosis (MDR-TB). In September 2010, the World Health Organization (WHO) convened an Expert Group to review the evidence on the accuracy of the Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA, United States) for the purpose of formulating recommendations to guide the use of the test. Policy recommendations on using Xpert MTB/RIF were issued by WHO early in 2011, supported by an operational how-to document and a checklist for implementation at the country level.
WHO's current policies and guidance recommend that Xpert MTB/RIF be used as an initial diagnostic test in individuals suspected of having MDR-TB or HIV-associated TB (strong recommendation, moderate quality of evidence). The guidance also provides a conditional recommendation that Xpert MTB/RIF be used as a follow-on test to smear microscopy in settings where MDR-TB or HIV are of lesser concern, especially for further testing of smear-negative specimens. In acknowledgement of the difficulties of obtaining microbiological confirmation of the diagnosis in children, this recommendation generalizes from data on adults to include the use of Xpert MTB/RIF in children.
Since 2010, more than 85 peer-reviewed research papers have been published on using Xpert MTB/RIF to diagnose pulmonary, extrapulmonary and paediatric TB, and studies continue to be performed. Given the amount of additional data on Xpert MTB/RIF that have emerged since 2010, an update of WHO's policies and guidance was warranted. WHO's Global TB Programme therefore commissioned three systematic reviews to update and revise the guidance; these reviews examined the utility of Xpert MTB/RIF in diagnosing TB and rifampicin resistance in pulmonary, extrapulmonary and paediatric TB. Published studies on the affordability and cost effectiveness of Xpert MTB/RIF were also reviewed. WHO convened an Expert Group to review the evidence at Les Pensierès, Veyrier-du-Lac, France during 20–21 May 2013. The major findings and recommendations of this Expert Group are summarized below, and a detailed meeting report is available at:
Copyright © World Health Organization 2013.
Sections
Similar articles
-
Xpert MTB/RIF Implementation Manual: Technical and Operational ‘How-To’; Practical Considerations.Geneva: World Health Organization; 2014. Geneva: World Health Organization; 2014. PMID: 25473699 Free Books & Documents. Review.
-
Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.Am J Respir Crit Care Med. 2011 Jul 1;184(1):132-40. doi: 10.1164/rccm.201101-0056OC. Epub 2011 Apr 14. Am J Respir Crit Care Med. 2011. PMID: 21493734
-
Benefits and challenges of molecular diagnostics for childhood tuberculosis.Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S4-S5. doi: 10.1016/j.ijmyco.2016.08.011. Epub 2016 Sep 20. Int J Mycobacteriol. 2016. PMID: 28043600
-
Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.Infect Dis Poverty. 2017 Jan 11;6(1):13. doi: 10.1186/s40249-016-0213-y. Infect Dis Poverty. 2017. PMID: 28086955 Free PMC article.
-
Policy Statement: Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System.Geneva: World Health Organization; 2011. Geneva: World Health Organization; 2011. PMID: 26158191 Free Books & Documents. Review.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials